The Phimie Fund acquires 90% of the pharmaceutical company Rafa at...

Yishai Davidi (Photo by Yonatan Blum)

The Pimi Fund, one of the leading private equity funds in Israel with assets under management of more than $ 5.5 billion, managed by Yishai Davidi, acquires 90% of the shares of the Rafa pharmaceutical company at a market value of approximately NIS 700 million. The Levin family, which is one of the current shareholders, will hold the remaining shares.

Gillon Beck, Pimi Shimona’s senior partner to the company’s chairman said: “The investment in Rafa Pharmaceuticals is a continuation of Pimi’s strategy in identifying companies with significant growth potential and expanding investments in pharmaceuticals. Rafa is a leading company in its field, the company’s products are marketed in Israel “Phimie intends to realize the significant growth potential she faces and to contribute from her knowledge and experience in improving companies and in Phimie’s broad global deployment.”

Amir Levin, The grandson of the company’s founder and CEO: “Phimie’s entry as Rafa’s senior and leading partner is good news, first and foremost for Rafa’s employees, its customers, and its business partners. Pimi will enable the continued operation of the plant in Jerusalem, and the promotion of Rafa’s business in Israel and in international markets. This is a significant day in the long history of the company, which is today run by the third generation of Rafa founders. I would like to thank the Scler family for their many years of joint activity, and contribution to the development of Rafa while maintaining a friendly and fair partnership. “

Comments on the article(0):

Your response has been received and will be published subject to system policies.
Thanks.

For a new response

Your response was not sent due to a communication problem, please try again.

Return to comment

These were the details of the news The Phimie Fund acquires 90% of the pharmaceutical company Rafa at... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at news1.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

NEXT China’s factory activity expands at fastest clip in 13 months, Caixin PMI shows